What happens when a curious biochemist follows his wife to California, falls in love with whitewater rafting — and accidentally makes one of the most important cancer discoveries of the 20th century?

In this episode, we sit down with Dr. Tony Hunter, the 2025 St. Gyorgi Prize winner and Salk Institute legend, whose 1979 discovery of tyrosine phosphorylation laid the foundation for over 80 cancer drugs in use today. We talk about the moment the scientific world accepted his discovery, why America's cancer research dominance is now under serious threat, the "valley of death" killing promising treatments before they reach patients, and what AI can — and can't — do for the future of cancer medicine.

Equal parts science, adventure, and a warning the research world needs to hear.

What if you could know your breast cancer risk at 25 and actually do something about it?

Dr. Funmi Olopade, a trailblazing oncologist at the University of Chicago, has spent 30 years rewriting the rules of breast cancer care, and she believes we can eradicate it as a cause of premature death within a decade.

In this episode, she breaks down how AI, genetic testing, and a simple blood test are transforming early detection, why too many women are still being failed by a broken system, and what every woman should be doing right now, no matter their age.

This is a conversation that could change how you think about your own health.

At age 37, Kathy Giusti was diagnosed with multiple myeloma and told she had just three years to live. Instead of accepting that fate, she turned urgency into action and founded the Multiple Myeloma Research Foundation (MMRF), transforming how cancer nonprofits accelerate drug development. Today, more than 15 therapies have been approved for multiple myeloma and survival rates have more than doubled.

In this episode of All Things Cancer, Dr. Sujuan Ba speaks with Kathy Giusti about her new book Fatal to Fearless, the leadership and strategy required to drive progress in cancer research, and how collaboration between nonprofits, academia, industry, and regulators can speed lifesaving treatments to patients.

They also explore the future of cancer research, including venture philanthropy, data sharing, AI-driven discovery, and why patients must be empowered to advocate for themselves in a complex medical system.